Jean-Laurent Casanova aims to identify single-gene mutations that compromise the immunity of normally healthy individuals and lead to severe infectious disease.
The company's microchip-based technology will detect viral and bacterial genetic material using both isothermal amplification and electrochemical measurements.
By genotyping nearly 200 Mycobacterium bovis isolates, investigators saw signs of introductions of the pathogen, coupled with a long history in the region.
